» Articles » PMID: 37047365

Crosstalk Between Genes and Long Non-Coding RNAs in Glioblastoma

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 13
PMID 37047365
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma (GBM) continues to be the most devastating primary brain malignancy. Despite significant advancements in understanding basic GBM biology and enormous efforts in developing new therapeutic approaches, the prognosis for most GBM patients remains poor with a median survival time of 15 months. Recently, the interplay between the (SRY-related HMG-box) genes and lncRNAs (long non-coding RNAs) has become the focus of GBM research. Both classes of molecules have an aberrant expression in GBM and play essential roles in tumor initiation, progression, therapy resistance, and recurrence. In GBM, and lncRNAs crosstalk through numerous functional axes, some of which are part of the complex transcriptional and epigenetic regulatory mechanisms. This review provides a systematic summary of current literature data on the complex interplay between genes and lncRNAs and represents an effort to underscore the effects of SOX/lncRNA crosstalk on the malignant properties of GBM cells. Furthermore, we highlight the significance of this crosstalk in searching for new biomarkers and therapeutic approaches in GBM treatment.

Citing Articles

Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.

Pei D, Zhang D, Guo Y, Chang H, Cui H Int J Mol Sci. 2025; 26(2).

PMID: 39859408 PMC: 11766336. DOI: 10.3390/ijms26020694.

References
1.
Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N . Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016; 7:13616. PMC: 5150648. DOI: 10.1038/ncomms13616. View

2.
Garcia I, Aldaregia J, Marjanovic Vicentic J, Aldaz P, Moreno-Cugnon L, Torres-Bayona S . Oncogenic activity of SOX1 in glioblastoma. Sci Rep. 2017; 7:46575. PMC: 5397861. DOI: 10.1038/srep46575. View

3.
Gheidari F, Arefian E, Jamshidi Adegani F, Atanaki F, Soleimani M . The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway. Iran J Pharm Res. 2022; 20(4):202-212. PMC: 8842594. DOI: 10.22037/ijpr.2021.115089.15193. View

4.
Chen Y, Wu J, Lin X, Bao Y, Chen Z, Zhang C . Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis. Int J Clin Exp Med. 2015; 8(4):5033-43. PMC: 4483865. View

5.
Torres-Bayona S, Aldaz P, Auzmendi-Iriarte J, Saenz-Antonanzas A, Garcia I, Arrazola M . PR-LncRNA signature regulates glioma cell activity through expression of SOX factors. Sci Rep. 2018; 8(1):12746. PMC: 6109087. DOI: 10.1038/s41598-018-30836-5. View